600351.SS
600351.SS
CNE000001CM5
YABAO PHARMACEUTICAL GROUP CO L
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 2.240.063.505 2.686.037.569
16.6%
Cost of Revenue 1.063.788.746 1.297.853.138
18.0%
Gross Profit 1.176.274.759 1.388.184.431
15.3%
826.560.341 1.049.068.771
21.2%
Operating Income 349.714.419 339.115.660
3.1%
Pretax Income 374.457.679 292.108.128
28.2%
Net Income Common Stockholders 320.013.386 242.688.462
31.9%
-- --
--
-- --
--
ende